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Background
The recent results of the RV144 trial demonstrate that
HIV-specific antibodies may provide protection from
infection. DNA vaccines may represent an important
HIV vaccine platform since they are safe, relatively inex-
pensive to manufacture, and stable at room temperature.
However, the platform has been used largely as a prime
modality limited to induce low level CD4 T cell
responses in NHP and humans. In this study we sought
to improve our current DNA vaccines to induce HIV-
specific antibodies with plasmid vaccination alone.
Methods
Groups of 5 Indian Rhesus Macaques were vaccinated
with pHIV consensus gag, pol, and clade C envelopes
delivered IM with in-vivo electroporation at weeks 0, 4
and 12. Immunogenicity was measured two weeks after
each dose.
Results
Three doses of an HIV DNA vaccine alone induced
robust cellular and antibody responses. Despite using
clade C based enveloped, high binding titers were
detectable against gp120s from multiple clades. Neutra-
lizing titers were in the 100’s range to a panel of clade B
and C tier 1 viruses. These data establish that designed
DNA envelop antigens can drive functional immunity in
NHP.
Conclusion
Multiple improvements to DNA vaccine technology
have significantly enhanced the immunogenicity of the
platform. Just three doses of a plasmid based HIV vac-
cine induced robust binding and neutralizing antibodies
as well as effector T-cell responses in NHP. We are
currently expanding the immunity induced by these
constructs through novel DNA adjuvants as well as in
prime-boost combinations.
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